Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Ustekinumab
Related studies linked through entity extraction aliases.
Biologics in Folliculitis Decalvans : an Adaptative Trial Research
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Risankizumab for Fibrostenotic Crohn's Disease Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
- Status
- RECRUITING
- Phase
- PHASE4
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
- Status
- RECRUITING
- Phase
- PHASE3
A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China
- Status
- COMPLETED
- Phase
- N/A
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Status
- RECRUITING
- Phase
- PHASE4
The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab
- Status
- COMPLETED
- Phase
- N/A
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.
- Status
- COMPLETED
- Phase
- N/A
Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
- Status
- RECRUITING
- Phase
- PHASE1
Effectiveness and Safety of Ustekinumab Intensification in Crohn's Disease
- Status
- UNKNOWN
- Phase
- N/A
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
- Status
- RECRUITING
- Phase
- N/A
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
- Status
- RECRUITING
- Phase
- N/A
A Multicentered Prospective Cohort Study of Chinese IBD Patients
- Status
- UNKNOWN
- Phase
- N/A